Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Arthritis Research & Therapy
Published in: Arthritis Research & Therapy 1/2005

01-02-2005 | Poster presentation

Oncostatin M in rheumatoid arthritis: a key cytokine acts synergistically with other proinflammatory cytokines to promote human cartilage loss

Authors: U Fearon, R Mullan, R Poole, T Markham, O FitzGerald, B Bresnihan, DJ Veale

Published in: Arthritis Research & Therapy | Special Issue 1/2005

Login to get access

Excerpt

Oncostatin M (OSM), an IL-6 type cytokine, is raised in the rheumatoid arthritis (RA) joint and correlates with markers of inflammation and cartilage destruction. This study explores the mechanistic role of OSM in cell adhesion, angiogenesis and matrix degradation. …
Metadata
Title
Oncostatin M in rheumatoid arthritis: a key cytokine acts synergistically with other proinflammatory cytokines to promote human cartilage loss
Authors
U Fearon
R Mullan
R Poole
T Markham
O FitzGerald
B Bresnihan
DJ Veale
Publication date
01-02-2005
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue Special Issue 1/2005
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar1582

Other articles of this Special Issue 1/2005

Arthritis Research & Therapy 1/2005 Go to the issue

Poster presentation

Does the burden of inflammation determined prospectively in patients with early inflammatory arthritis determine the progression of atherosclerosis?

Poster presentation

Efficient IL-18 and IL-18BPc adenoviral gene transfer to cultured murine submandibular gland epithelial cells and successful murine retrograde submandibular duct cannulation to modulate IL-18 function in the salivary gland of animal models of Sjogren's syndrome

Poster presentation

Investigation of the relationship between the HLADRB1 genotype and the presence of autoantibody to cyclic-citrullinated peptide in patients with rheumatoid arthritis

Poster presentation

Prevalence and specificity of autoantibodies to defensins in sera of patients with systemic autoimmune diseases

Poster presentation

Distinct patterns of RANKL/osteoprotegerin system modulation through anti-tumour necrosis factor and corticosteroid therapy in rheumatoid arthritis synovium

Poster presentation

Characteristics and outcomes in sero-positive late-onset rheumatoid arthritis patients who start a new disease modifying anti-rheumatic drug
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits